Kyle Piskel Adaptive Biotechnologies Corp (ADPT) insider trading activity
Kyle Piskel is Chief Financial Officer of Adaptive Biotechnologies Corp. Currently has a direct ownership of 154,578 shares of ADPT, which is worth approximately $820,809. The most recent transaction as insider was on May 15, 2024, when has been sold 31,260 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
155K
0%
3M change
76.53%
12M change
Total Value Held
$820,809
KYLE PISKEL Transaction History
KP
Kyle Piskel
Chief Financial Officer
Seattle, WA